Any current/future capex/capital investment/strategic investment?

For FY 2023-24, Venky’s Limited plans only routine capital expenditure. One new project has been started in the Animal Health Products (AHP) segment. The estimated cost of this new AHP project is around INR 50 crores. Funding for this capex will come entirely from internal accruals; no external funding is planned. No other diversification or new strategic investments have been announced at present.

Any current/future new fundraising through debt or equity?

Venky’s Limited does not plan any new external funding. The capital expenditure for FY 2023-24, including a new animal health products project costing around INR 50 crores, will be funded entirely from internal generation. No new debt or equity fundraising is being undertaken or planned according to the management’s statements during the call.

Future growth expectations in sales/revenue/volumes?

Poultry segment expected growth: 8% to 10% in volume terms for FY 2023-24. Oilseed segment volume growth anticipated: 7% to 10%, though value growth is uncertain and market-driven. Animal health products: Flat revenue last year due to restructuring; expected growth of 15% to 17% in FY 2023-24. Broiler day-old chicks sales increased from 10.56 crores to 11.31 crores; commercial broiler bird volumes also rose slightly. Quick Service Restaurants (QSR) sector expanding around 10% annually, with a shift from A-grade to B-grade cities, indicating growth potential. Continuous new product la

Future growth expectations in earnings/operating earnings/profits/EPS?

Poultry segment volume growth expected at 8%-10%, but profitability remains volatile due to raw material (maize, soya) price fluctuations. Predicting steady profits is challenging. Animal Health Products forecasted for 15%-17% growth in FY 2023-24, following a flat previous year due to restructuring. Oilseed segment volume growth expected at 7%-10%, with margins around 3%, though value growth is unpredictable due to commodity price volatility. The company is shifting focus from volatile poultry business to more stable, non-volatile segments like processed foods and AHP, aiming for steadi

Venkys (India) LtdQ4 FY23Food Products

Venkys (India) Ltd Q4 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,504.3P/E: 12.2Market Cap: ₹2.1K CrSector: Food Products

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

Poultry segment expected growth: 8% to 10% in volume terms for FY 2023-24.
Oilseed segment volume growth anticipated: 7% to 10%, though value growth is uncertain and market-driven.
Animal health products: Flat revenue last year due to restructuring; expected growth of 15% to 17% in FY 2023-24.
Broiler day-old chicks sales increased from 10.56 crores to 11.31 crores; commercial broiler bird volumes also rose slightly.
Quick Service Restaurants (QSR) sector expanding around 10% annually, with a shift from A-grade to B-grade cities, indicating growth potential.
Continuous new product launches planned, especially in processed food branded products, to expand market reach.
Capex of INR 50 crores for new animal health products project funded from internal accruals, supporting growth.

Margin guidance

Category 3

Poultry segment volume growth expected at 8%-10%, but profitability remains volatile due to raw material (maize, soya) price fluctuations. Predicting steady profits is challenging.
Animal Health Products forecasted for 15%-17% growth in FY 2023-24, following a flat previous year due to restructuring.
Oilseed segment volume growth expected at 7%-10%, with margins around 3%, though value growth is unpredictable due to commodity price volatility.
The company is shifting focus from volatile poultry business to more stable, non-volatile segments like processed foods and AHP, aiming for steadier profits.
No major diversification planned; capital expenditure limited to the new animal health product project (~INR 50 crore) funded internally.
Overall, long-term growth is anticipated through expansion in branded products, processed foods, and QSR sourcing, with moderate volume growth across segments expected.

See what Venkys (India) Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Venky’s Limited does not plan any new external funding.
The capital expenditure for FY 2023-24, including a new animal health products project costing around INR 50 crores, will be funded entirely from internal generation.
No new debt or equity fundraising is being undertaken or planned according to the management’s statements during the call.

Order book

The transcript does not provide specific details on Venky's Limited's current or expected order book or pending orders. However, relevant information regarding business segments and growth expectations includes: - Venky’s supplies to around eight leading QSRs like KFC, Pizza Hut, Taco Bell, McDonald’s, indicating ongoing and stable demand. - The company is actively launching new processed food products, with some new products planned for the next quarter, suggesting healthy order inflow in that segment. - Growth outlook for poultry and oilseed volume is projected around 7% to 10% for FY ‘24. - Capital expenditure includes a new INR 50 crore project on animal health products, funded internally, signaling business expansion. - Pricing contracts with QSRs have been largely fixed for the next six months, implying secured orders in the near term. No explicit mention of exact orderbook or pending order values is available in the transcript.

See what Venkys (India) Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

For FY 2023-24, Venky’s Limited plans only routine capital expenditure.
One new project has been started in the Animal Health Products (AHP) segment.
The estimated cost of this new AHP project is around INR 50 crores.
Funding for this capex will come entirely from internal accruals; no external funding is planned.
No other diversification or new strategic investments have been announced at present.

Track Venkys (India) Ltd — get its next earnings analysis in your feed

How does Venkys (India) Ltd rank vs peers in Food Products?

Pro feature

ThisVenkys (India) Ltd

Rev 4Mar 3

See where Venkys (India) Ltd sits in Food ProductsSee which companies these are, and every other name in the sector.Open rankings

How does Venkys (India) Ltd rank in Food Products?

Compare Venkys (India) Ltd against every Food Products company (Q4 FY23) on revenue, margins and earnings-call signals.

View Food Products leaderboard →

What Venkys (India) Ltd's management said in earlier quarters

Others in Food Products this season

Prataap Snacks Ltd (Q2 FY27)
Q2 FY27 income from operations was ₹540.95 crore, a 25.9% increase year-on-year (YoY). Key results statement takeaways from Prataap Snacks Ltd's Q2 FY27 results
Madhusudan Masa (Q2 FY27)
4,158.28 lakh (Q2 2025), approximately +118% YoY. Key results statement takeaways from Madhusudan Masala Ltd's Q2 FY27 results statement — and how it ranks agai
Vadilal Industries Ltd (Q2 FY27)
Revenue from operations for the quarter ended September 30, 2026: ₹462.56 crore (Consolidated, Page 11) . Key results statement takeaways from Vadilal Industrie
Wardwizard Foods & Beverages Ltd (Q1 FY27)
Revenue for Q1 FY27 (June 2026 quarter) is ₹17.03 Cr, up from ₹13.20 Cr in Q1 FY26, reflecting a strong year-on-year growth. Key investor presentation takeaways

Compare:vs Nestle India vs Britannia Inds.vs Milky Mist Dairy Food Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →